When Evidence Burns: Abortifacient Ideology and the FDA

Nearly $10 million worth of birth control products purchased by the U.S. Agency for International Development (USAID) are slated for incineration at the direction of the Trump Administration, which falsely claims they cause abortions.

These products were intended for women in low-income countries, where access to reliable contraception is critical for poverty reduction efforts. Contraceptives are public health interventions that prevent maternal mortality, allow families to safely space pregnancies, and break cycles of oppression that perpetuate poor health outcomes across generations.

Despite offers from several global health organizations to buy the products and cover storage and distribution costs, the Trump Administration is opting to destroy the collection of IUDs and hormonal pills and implants currently held in a Belgian warehouse. The destruction will cost taxpayers approximately $167,000. 

USAID, which has been shut down with 83% of its programs cut and is now finishing its work through the State Department, is historically legally prohibited from procuring abortifacients, which are any compound that induces abortion. Since the passage of the 1973 Helms Amendment, USAID’s family planning programs have been barred from using funds for abortions. The contraceptives passed through the stringent vetting. The “fetal personhood agenda,” which seeks to ban abortion, falsely asserts that FDA-approved contraceptive methods, such as those stored in the Belgian warehouse, prevent implantation of a fertilized egg. By this skewed logic, contraceptives are a category of abortifacients. 

This decision is more than wasteful; it undermines decades of global health progress and signals a larger problem: policymaking that overrides evidence to favor political ideology. 

A Pattern: Contraceptives to Vaccines

Declaring Food and Drug Administration (FDA)-approved interventions morally suspect also underpins efforts to restrict routine vaccinations. Increasingly, vaccines are framed not merely as unsafe or unproven, but as violations of civil liberties, cultural and religious freedom, or natural law, casting immunization as a moral transgression rather than a public health obligation. Like the proposed contraceptive incineration, these actions treat medically regulated, evidence-based products as morally impermissible, substituting ideology for science and collapsing nuanced medical realities into a political agenda. 

In addition, officials have argued that the contraceptive destruction plan was a cost-saving measure. This is belied by the numbers: $9.7 million in product value and $167,000 in costs for destruction. The administration’s real rationale, anti-abortion policy, is part of a broader dismantling of government agencies and a deeper dismemberment of health infrastructure. 

The choice to destroy signals ideological homogeneity at the expense of public health, fiscal responsibility, and U.S. credibility as a leader in global health. 

Designating two medically proven interventions, contraception and vaccines, to be “life-ending interventions” erases scientific validity and redefines medicine through an ideologically absolutist lens. This effort to relabel evidence-based, population-level interventions as inherently harmful disregards scientific consensus about how these products have been proven to work. Importantly, it also shifts decision-making away from an evidentiary basis to a partisan loyalty test, where health becomes a referendum on virtue rather than a clinical need. The result is a de facto shadow regulatory regime.

The FDA’s Role 

The FDA was created precisely to avoid this kind of ad hoc decision-making. Its mandate emerged from health incidents like the sulfanilamide disaster of 1937, which exemplified how public health cannot be left to unregulated political market influences. When Elixir Sulfanilamide was pushed to patients to treat streptococcal infections without prior safety testing, it resulted in a mass poisoning, where more than 100 people across 15 states died. This prompted the passage of the 1938 Food, Drug, and Cosmetic Act, increasing the authority of the FDA to regulate medical products for safety. In 1902, Congress passed the Biologics Control Act, giving what became the FDA’s Center for Biologics Evaluation and Research (CBER) legal oversight for biological products like vaccines. 

The FDA is a public trust mechanism. Its legitimacy rests on its ability to ensure that products reaching the public are evaluated with evidence that is testable, reproducible, and transparent, not subject to shifting political sentiments.

Departing from Evidence 

Destroying FDA-approved contraceptives does nothing to make the public safer. It eliminates access to proven tools, wastes taxpayer dollars, and is a further degradation of trust in global health commitments. Abandoning the communities these products were meant to serve deepens the global health gap and undermines investment. 

This same pattern is evident across domestic health policy: the widespread restriction of COVID-19 vaccine access, despite expert input that doing so would increase preventable hospitalizations; the cancellation of funding for avian flu vaccines, even amid warning from public health officials of a looming pandemic risk; and proposals to eliminate FDA advisory committee reviews for new drugs, which would threaten to strip away one of the agency’s most viable mechanisms for evidence-based decision-making. In each case, expertise is set aside in favor of ideological signaling, the very dynamic the FDA was designed to insulate against. 

Safety, Not Snake Oil

The FDA has been criticized for being too slow, paternalistic, and impeding innovation, especially for methodologically difficult interventions, such as psychedelic-assisted therapies and cell and gene therapies. There is merit to calls for modernizing trial designs and exploring adaptive and pragmatic approaches. But modernization must not mean abandoning the FDA’s epistemic core. FDA exists not merely to keep unsafe drugs off the market, but to prevent the normalization of products and practices that exploit vulnerable populations or bypass scientific scrutiny entirely. Without this standard, a marketplace where ideology and profit, not evidence, dictate who receives care and who is left behind. 

Evidence Against Partisan Arson 

The USAID case is a symptom of the greater pervasive erosion of the evidence infrastructure that underpins American policymaking. 

The FDA ought to assert its role as the nation’s arbiter of medical evidence, using its authority to demand transparency in public, dissenting scientific analyses when political decisions override expert consensus, and call out attempts to bypass its review process. But this is only possible if efforts to hollow out its evidentiary mission are resisted. Rather than quietly absorbing political pressure, the FDA must become a visible custodian of evidence, building ethical safeguards that make ideological overrides both costly and rare.